申请人:ASTELLAS PHARMA INC
公开号:WO2005110981A1
公开(公告)日:2005-11-24
The present invention relates to a compound formula[I]: wherein X is bond or -O-, R1 is formula[A] or formula [B] in which R5, R6 and R7 are each as defined in the description, R2 is hydrogen or lower alkyl, R3 is hydrogen or an amino protective group , R4 is formula[C], [D] or [E] in which R8, R9, R10, R11, R12, R13 and R16 are each as defined in the description, and R14 and R15 are each independently hydrogen or lower alkyl, or a prodrug thereof or a salt thereof. The compound [I] of the present invention and pharmaceutically acceptable salts thereof are useful for the prophylactic and/or the therapeutic treatment of overactive bladder, micturiation disorder and the like.
本发明涉及一种化合物公式[I]:其中X是键或-O-,R1是公式[A]或公式[B],其中R5、R6和R7如描述中所定义,R2是氢或低碳基,R3是氢或氨基保护基,R4是公式[C]、[D]或[E],其中R8、R9、R10、R11、R12、R13和R16如描述中所定义,R14和R15各自独立地是氢或低碳基,或其前药或盐。本发明的化合物[I]及其药学上可接受的盐对于预防和/或治疗过度活跃膀胱、排尿障碍等方面是有用的。